Clover Health Investments (CLOV) Change in Account Payables (2020 - 2026)

Clover Health Investments (CLOV) has 7 years of Change in Account Payables data on file, last reported at -$65.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Account Payables fell 50.3% year-over-year to -$65.3 million; the trailing twelve-month figure through Mar 2026 stood at -$44.5 million (down 215.07% YoY), and the FY2025 full-year result was -$22.6 million, down 17.96% from the prior year.
• Change in Account Payables for Q1 2026 stood at -$65.3 million, down from -$18.3 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $109.2 million in Q3 2022 and bottomed at -$94.8 million in Q4 2022.
• The 5-year median for Change in Account Payables is -$13.6 million (2023), against an average of -$5.5 million.
• The widest annual swing landed in 2022, when Change in Account Payables plunged 1702.3%; it then jumped 342.43% in 2024.
• A 5-year view of Change in Account Payables shows it stood at -$94.8 million in 2022, then soared by 93.22% to -$6.4 million in 2023, then tumbled by 215.55% to -$20.3 million in 2024, then advanced by 9.78% to -$18.3 million in 2025, then plunged by 256.95% to -$65.3 million in 2026.
• The last three Change in Account Payables figures came in at -$65.3 million (Q1 2026), -$18.3 million (Q4 2025), and $38.9 million (Q3 2025), per Business Quant data.

Peer Comparison